AUG 10, 2026 · JOURNAL ARTICLE
Cost-effectiveness of targeted therapy versus chemotherapy for patients with advanced or metastatic gastric cancer in China
Frontiers in Pharmacology
A single-centre modelling study using a hybrid decision tree and Markov model with assumed parameters, not a clinical trial; provides economic perspective but lacks empirical validation of clinical inputs and generalizability.
Reported
Incremental cost$64,242.13
Incremental QALYs0.63
Incremental cost-effectiveness ra…$101,278.5/QALY